Agios Pharmaceuticals, Inc. (AGIO) Institutional Ownership

Institutions by Trading Activity

Ownership Statistics

0Shares Outstanding

817,668Shares held by institutions

$24,219,326Value of institutional holdings

104.94%Institutional ownership %

-1.48%Shares Changed QoQ

211No. of institutional investors

Shares Owned by Institutions

Shares Purchased/Sold by Institutions

Ownership Summary

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is held by 232 institutional investors per 13F filings through December 2025.

These investors held 104.4% of outstanding shares in December 2025, down from 121.6% in September 2025.
Their total shares held in AGIO increased 13.09% quarter over quarter, and separately, investors owning Agios Pharmaceuticals increased 4.98% from a year ago.
During the quarter, 142 of these 232 funds increased positions in AGIO, 66 reduced exposure, and 24 held steady.
The aggregate institutional position in Agios Pharmaceuticals amounted to 60.9Mn shares as of December 2025, up by 7.05Mn shares quarter on quarter, and down 1.8Mn shares year over year.
VANGUARD GROUP INC holds the largest position in AGIO at 5.59Mn shares as of December 31, 2025, or 9.59% of shares outstanding.
The largest buyers of Agios Pharmaceuticals for the quarter ending December 2025 were ARMISTICE CAPITAL, LLC (2.27Mn), NOMURA ASSET MANAGEMENT INTERNATIONAL INC. (1.7Mn), D. E. Shaw & Co., Inc. (1.47Mn), MPM BioImpact LLC (1.3Mn), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.14Mn).
Top sellers of AGIO stock for the quarter ending December 2025 included FARALLON CAPITAL MANAGEMENT LLC (6.4Mn), WELLINGTON MANAGEMENT GROUP LLP (1.87Mn), Bank Of America Corp /De/ (1.72Mn), DEUTSCHE BANK AG\ (803.86K), BOOTHBAY FUND MANAGEMENT, LLC (458.05K).
Per Business Quant data, the top 10 holders of Agios Pharmaceuticals for the quarter ending December 2025 are VANGUARD GROUP INC (5.59Mn), BlackRock, Inc. (5.24Mn), FARALLON CAPITAL MANAGEMENT LLC (5.16Mn), State Street Corp (3.11Mn), ARMISTICE CAPITAL, LLC (3.04Mn), Erste Asset Management GmbH (2.8Mn), D. E. Shaw & Co., Inc. (1.84Mn), NOMURA ASSET MANAGEMENT INTERNATIONAL INC. (1.7Mn), GEODE CAPITAL MANAGEMENT, LLC (1.41Mn), BNP Paribas Asset Management Holding S.A. (1.36Mn).

232 Institutional Holders

817,668 Total Shares Held

Rows:

Download Data

Owner Name	Date	Change (QoQ)	Change (%)	Value (USD)
BlackRock, Inc.	31 Dec, 2025	689,691	15.17%	$0.00
VANGUARD GROUP INC	31 Dec, 2025	-10,523	-0.19%	$0.00
Erste Asset Management GmbH	31 Dec, 2025	40,000	1.45%	$0.00
Barclays Plc	31 Dec, 2025	-76,105	-19.20%	$0.00
FARALLON CAPITAL MANAGEMENT LLC	31 Dec, 2025	-6,402,627	-55.38%	$0.00
MPM BioImpact LLC	31 Dec, 2025	1,303,373	0.00%	$0.00
Rockefeller Capital Management L.P.	31 Dec, 2025	216,461	1,349.68%	$0.00
State Street Corp	31 Dec, 2025	845,433	37.36%	$0.00
Frazier Life Sciences Management, L.P.	31 Dec, 2025	0	0.00%	$0.00
ARMISTICE CAPITAL, LLC	31 Dec, 2025	2,272,000	297.38%	$0.00
TCG Crossover Management, LLC	31 Dec, 2025	-248,200	-17.36%	$0.00
D. E. Shaw & Co., Inc.	31 Dec, 2025	1,469,437	399.58%	$0.00
Foresite Capital Management VI LLC	31 Dec, 2025	530,000	0.00%	$0.00
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	31 Dec, 2025	1,701,409	0.00%	$0.00
Qube Research & Technologies Ltd	31 Dec, 2025	378,373	0.00%	$0.00
GEODE CAPITAL MANAGEMENT, LLC	31 Dec, 2025	-2,777	-0.20%	$0.00
ADAR1 Capital Management, LLC	31 Dec, 2025	339,000	916.22%	$0.00
BNP Paribas Asset Management Holding S.A.	31 Dec, 2025	373,391	37.82%	$0.00
Vestal Point Capital, LP	31 Dec, 2025	198,000	155.91%	$0.00
CITADEL ADVISORS LLC	31 Dec, 2025	856,986	174.19%	$0.00

1 - 20 of 232

Research Tools